TRIANA Biomedicines’ Post

Would you like to learn more about the unique Norwegian ECG247 and how it has been used in a number of medical trials? Meet me at MEDICA!

We were delighted to welcome Dr Jörg Duschmalé, a board member of Roche, Karger Publishers, and PolG Foundation to our recent High Performance Boards program at IMD. As a member of Roche's founding family and with a business history spanning 128 years, Dr Duschmalé's journey in the company began in the laboratory. He emphasised the unique perspective he brings to the boardroom as a scientist and chemist, stating, "As a board member, I can contribute in unique ways. With my background in R&D, I have an intimate understanding of the challenges we face." In today's increasingly challenging business environment, Dr Duschmalé acknowledges that the governance structure of family businesses like Roche offers an advantage by fostering a long-term view for future generations. However, he also presents his own perspective. “I always think if family ownership works and if it is a competitive advantage. If it does not work, it really does not work. Looking at the journey of my own family over 128 years it was not always a straight-line success story. There were difficulties, but the key lies in the family's agreement that what benefits the company ultimately benefits the family. It is successful, but it can be a risky model.” #highperformanceboards #imdboardcenter #geopolitics #corporategovernance #boardofdirectors #familybusiness #randd  

Medine maintained a solid pace of growth for the third quarter of 2023/24. Revenue rose 60% to a record Rs 2.7 billion, while gross profits rose by 69% to Rs 604 million for the first nine months of the financial year. Sales from Property operations almost tripled to Rs 1.3 billion, while gross profits doubled to Rs 235 million. Revenue from the Education segment increased by 17% while revenue from our Agriculture and Leisure businesses also increased. These results reflect the continued operational and financial progress of each of the Group’s business units. The Group is confident of ending the financial year on a positive note. Read more here: https://lnkd.in/d8SWAT-V

Today the Consolis Annual Financial and Sustainability Report 2023 is launched! A great read for anyone interested in precast concrete and learning about our journey towards net-zero emissions and the Green Spine Line. #wellbuiltforwellbeing

This morning, Claire Marrazzo Greenwood, Executive Director of the CEO Council for Growth, and Senior Vice President of Economic Competitiveness at the Chamber joined Governor Josh Shapiro to celebrate a major win for Greater Philadelphia’s life sciences sector and Pennsylvania’s economy: Adare Pharma Solutions's $16.8 million investment in our region, creating 115 new jobs on top of 200 existing positions. Read more about this impactful investment and how the Chamber is supporting the growth of our region through Select Greater Philadelphia: https://lnkd.in/eNXngr74 #GoodBizPHL

#TRIZAsia #GENTRIZLLC Is your organization facing Complex Product, Process, Business innovation challenges? We use a scientific problem-solving approach to identify the right targets for innovation and develop cost-effective solutions. We also have a Global Knowledge Network (GKN) of over 8000 scientist and technical experts that we leverage to gain a deeper level of subject matter expertise. For more details, please write to us on info@trizasia.com

Our clients’ success is our pride! Experience Urochem’s impact today and see the difference we make. #Urochem #ClientSuccess #InnovationThatMatters #MakingAnImpact #TrustedPartner #ExcellenceInAction #UrochemSolutions #PrideInPerformance #CustomerFirst #SuccessStories

Rhythm Biosciences Limited Explore key financial insights stemming from Rhythm Biosciences' recent tax incentive announcement and its implications for operational growth. Read More https://lnkd.in/gAr9s24t #RhythmBiosciences, #FinancialStability, #CashFlow, #DebtManagement, #ColoSTAT

Collaborative innovations starts with great partnerships.

📊 Market Movers Update 📊 The last trade session saw significant fluctuation among top gainers and losers. Garden Stage Limited led the day among gainers with a substantial leap, displaying innovative strategies and strong market presence in the Finance sector. The Utilities arena also saw a winner - Zeo Energy Corporation, whereas, the Commercial services sector enjoyed good returns with Telesis Bio, Inc. making its mark in positive uptrends. Unfortunately, every rose has its thorn. The same Commercial service sector experienced a drop with SBC Medical Group Holdings Incorporated facing a downturn, followed by Progyny, Inc. Likewise, the Health technology sector saw Aligos Therapeutics, Inc. experiencing a decrease. In conclusion, the current stock market represents fluctuating dynamics – an arena worth close attention for veteran investors and newcomers alike. 💡 Key Insights: ✅ Garden Stage Limited, Zeo Energy Corporation, and Telesis Bio, Inc. are displaying impressive growth and strong market presence. ✅ SBC Medical Group Holdings, Progyny, Inc., and Aligos Therapeutics, Inc. bear monitoring, due to the potential impacts of their recent downturns. ✅ A versatile investment strategy across diverse sectors might mitigate risk and harness opportunities better. For more information please visit: https://lnkd.in/eaU-2-r9 Stay informed, stay ahead. 🚀 #Trading #MarketNews #Investing #StockMarket #Finance #Utilities #CommercialServices #HealthTech Content shared by Zimtra is for informational purposes only, and not trading advice. Always do your own research before making any investment., Click https://lnkd.in/esZaUsZ8 for more information.